| Factor Information | |
|---|---|
| Data ID | 1318 |
| Factor | previous shunt |
| Description | Total scar extension, expressed as % of total endocardial area, was significantly higher in patients with previous shunt [4.0% (±2.7) vs 2.6% (±2.2), p = 0.01]. |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Total scar extension |
| p Value | 0.01 |
| Conclusion | Patients with rCHD involving the right ventricle show electrical scars with variable distribution, not necessarily matching with sites of surgical lesions. Scar extension correlates with some of the risk factors for lifethreatening arrhythmias in CHD, such as prolonged QRS. Thus EVM could be considered an additional tool in the assessment of risk stratification in this particular population. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 516 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/PA, VSD/PS, DORV/PS, VSD/PS, DORV, VSD/DORV, VSD |
| Reference | |
|---|---|
| PMID | 27505328 |
| Year | 2016 |
| Title | Role of right ventricular three-dimensional electroanatomic voltage mapping for arrhythmic risk stratification of patients with correctedTOF or other congenital heart disease involving the right ventricular outflow tract. |
| Sample | ||
|---|---|---|
| Population | Adults | |
| Source | N/A | |
| Region | Rome, Italy | |
| Method | right ventricular (RV) electroanatomic voltage mapping | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | Type of correction: Transannular patch, Non-transannular patch, RV-to-pulmonary artery conduit, Other; Pulmonary valve replacement: Surgical, Percutaneous. | |
| Group | Present(Treatment) | Absent(Control) |
| Number | 146 | N/A |
| Age | 19.2 (±7.0) years | 19.2 (±7.0) years |
| Gender (Male: Female) | 88:58 | N/A |
| Marker Level | 4.0% (±2.7) | 2.6% (±2.2) |
